Literature DB >> 12013322

The Avoid Stroke as Soon as Possible (ASAP) general practice stroke audit.

Jonathan W Sturm1, Stephen M Davis, John G O'Sullivan, Miriam E Vedadhaghi, Geoffrey A Donnan.   

Abstract

OBJECTIVES: To determine the prevalence of stroke risk factors in a general practice population and to identify pharmacotherapies currently used in management of stroke risk factors.
DESIGN: Multicentre, observational study by 321 randomly selected general practitioners who each collected data on 50 consecutive patients attending their surgery. PATIENTS AND
SETTING: 16 148 patients aged 30 years or older attending general practices across Australia during 2000. OUTCOME MEASURES: Prevalence of hypertension, current smoking, diabetes, hypercholesterolaemia, atrial fibrillation, recent history of stroke or TIA; extent of pharmacotherapy use in risk-factor management.
RESULTS: 70% of patients had one or more risk factors and 34% had two or more. Hypertension was the risk factor with greatest prevalence (44%), followed by hypercholesterolaemia (43%) and current smoking (17%). The prevalence of risk factors generally increased with age, except for current smoking, where a decrease with age was seen. The most common pharmacotherapies were cardiovascular agents, followed by antiplatelet agents. Two-thirds of patients with hypertension were taking cardiovascular drugs, most commonly angiotensin-converting enzyme inhibitors.
CONCLUSIONS: Stroke risk factors are highly prevalent in general practice patients and GPs are ideally placed for opportunistic case-finding. There is considerable scope for improving management of stroke risk factors. The Avoid Stroke as Soon as Possible (ASAP) general practice stroke audit provides a baseline against which progress in risk-factor management can be measured.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12013322     DOI: 10.5694/j.1326-5377.2002.tb04430.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  9 in total

1.  The Cerebrovascular Attitudes and Beliefs Scale (CABS-R): the factor structure and psychometric properties of a tool for assessing stroke-related health beliefs.

Authors:  Karen A Sullivan; Katherine M White; Ross McD Young; Clinton Scott
Journal:  Int J Behav Med       Date:  2010-03

Review 2.  Global epidemiology of atrial fibrillation.

Authors:  Faisal Rahman; Gene F Kwan; Emelia J Benjamin
Journal:  Nat Rev Cardiol       Date:  2014-08-12       Impact factor: 32.419

3.  A community-based study on electrocardiographic abnormalities of adult population from South India - Findings from a cross sectional survey.

Authors:  Mangalath Narayanan Krishnan; Zachariah Geevar; Krishnan Nair Venugopal; Padinhare Purayil Mohanan; Sivadasanpillai Harikrishnan; Ganapathi Sanjay; Shanmugasundaram Devika; Kavumpurathu Raman Thankappan
Journal:  Indian Heart J       Date:  2022-05-13

Review 4.  The Optimal Treatment For Atrial Fibrillation In Less Developed Countries.

Authors:  Xiaohan Fan; Shu Zhang
Journal:  J Atr Fibrillation       Date:  2014-10-31

5.  Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study.

Authors:  Linda J Cobiac; Anne Magnus; Jan J Barendregt; Rob Carter; Theo Vos
Journal:  BMC Public Health       Date:  2012-06-01       Impact factor: 3.295

6.  Study protocol: the DESPATCH study: delivering stroke prevention for patients with atrial fibrillation - a cluster randomised controlled trial in primary healthcare.

Authors:  Melina Gattellari; Dominic Y Leung; Obioha C Ukoumunne; Nicholas Zwar; Jeremy Grimshaw; John M Worthington
Journal:  Implement Sci       Date:  2011-05-20       Impact factor: 7.327

7.  Improving stroke prevention therapy for patients with atrial fibrillation in primary care: protocol for a pragmatic, cluster-randomized trial.

Authors:  Theresa M Lee; Noah M Ivers; Sacha Bhatia; Debra A Butt; Paul Dorian; Liisa Jaakkimainen; Kori Leblanc; Dan Legge; Dante Morra; Alissia Valentinis; Laura Wing; Jacqueline Young; Karen Tu
Journal:  Implement Sci       Date:  2016-12-03       Impact factor: 7.327

8.  Prescribing Data in General Practice Demonstration (PDGPD) project--a cluster randomised controlled trial of a quality improvement intervention to achieve better prescribing for chronic heart failure and hypertension.

Authors:  Margaret Williamson; Magnolia Cardona-Morrell; Jeffrey D Elliott; James F Reeve; Nigel P Stocks; Jon Emery; Judith M Mackson; Jane M Gunn
Journal:  BMC Health Serv Res       Date:  2012-08-23       Impact factor: 2.655

9.  The management of non-valvular atrial fibrillation (NVAF) in Australian general practice: bridging the evidence-practice gap. A national, representative postal survey.

Authors:  Melina Gattellari; John M Worthington; Nicholas A Zwar; Sandy Middleton
Journal:  BMC Fam Pract       Date:  2008-11-13       Impact factor: 2.497

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.